Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€5.20

€5.20

-1.940%
-0.1
-1.940%
-
 
26.01.26 / Tradegate WKN: A40ZVN / Name: Viromed Medical / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Viromed Medical AG Stock

A loss of -1.940% shows a downward development for Viromed Medical AG.

Pros and Cons of Viromed Medical AG in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: Correction of a release from 19/01/2026, 11:45 CET/CEST - Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval
EQS-News: Correction of a release from 19/01/2026, 11:45 CET/CEST - Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval
EQS-News: Correction of a release from 19/01/2026, 11:45 CET/CEST - Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval
EQS-News: Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval
EQS-News: Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval
EQS-News: Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval